Abingdon Health PLC ABDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- GBX11.00
- Day Range
- GBX10.50–11.50
- 52-Week Range
- GBX5.50–13.00
- Bid/Ask
- GBX0.00 / GBX0.00
- Shares Outstanding
- 252.75M
- Market Cap
- GBX2.72B
- Volume/Avg
- 115,283 / 103,767
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.45
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 129
- Website
- https://www.abingdonhealth.com
Valuation
|
Metric
|
ABDX
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 4.79 |
Price/Sales | 4.45 |
Price/Cash Flow | — |
Price/Earnings
ABDX
Financial Strength
|
Metric
|
ABDX
|
|---|---|
Quick Ratio | 1.73 |
Current Ratio | 1.91 |
Interest Coverage | −40.40 |
Quick Ratio
ABDX
Profitability
|
Metric
|
ABDX
|
|---|---|
Return on Assets (Normalized) | −32.01% |
Return on Equity (Normalized) | −56.32% |
Return on Invested Capital (Normalized) | −45.14% |
Return on Assets
ABDX
Diagnostics & Research Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|>T<?jVq# | LOCK|dz | $250B | |||
| Danaher Corp
DHR
| LOCK|?SQ<Sh! | LOCK|@p | $156B | |||
| Agilent Technologies Inc
A
| LOCK|#%VxQ$x& | LOCK|T>@ | $48B | |||
| Illumina Inc
ILMN
| LOCK|kvm%NTC | LOCK|d^hcK | $44B | |||
| IQVIA Holdings Inc
IQV
| LOCK|?<dbjY | LOCK|hJH< | $44B | |||
| Waters Corp
WAT
| LOCK|$FBP@> | LOCK|q# | $43B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|F%$vQpq | LOCK|b^ | $42B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|?$?#V^@ | LOCK|^?lTM | $31B | |||
| Quest Diagnostics Inc
DGX
| LOCK|Zg>?NML | LOCK|Zd@H | $26B | |||
| Guardant Health Inc
GH
| LOCK|M&#Vk<m | LOCK|scQ | $25B |
United States